CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus

International Journal of Cancer

Volumn 69, Issue 4, 1996, Pages 254-258

  Dean Roye, G ^a   Myers, Russell B ^b   Brown, David ^c   Poczatek, Robert ^b   Beenken, Samuel W ^a   Grizzle, William E ^b  

^a Kentucky   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ARTICLE; CONTROLLED STUDY; DYSPLASIA; ESOPHAGUS CARCINOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; EPITHELIUM; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; IMMUNOHISTOCHEMISTRY; SURVIVAL RATE;

EID: 9544258287     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960822)69:4<254::AID-IJC2>3.0.CO;2-W     Document Type: Article

References (27)

1. BIRCH, M., MITCHELL, S. and HART, I.R., Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res., 51, 6660-6667 (1991).
2. BLOT, W.J., Esophageal cancer trends and risk factors. Semin. Oncol., 21, 403-410 (1994).
3. BORING, C.C., SQUIRES, T.S., TONG, T. and MONTGOMERY, S., Cancer Statistics, 1994, Ca. Cancer J. Clin., 44, 7-26 (1994).
4. FOX, S.B., GATTER, K.C., JACKSON, D.O., SCREATON, G.R., BELE, M.V., BELL, J.I., HARRIS, A.L., SIMMONS, D. and FAWCETT, J., CD44 and cancer screening [Letter to Editor]. Lancet, 342, 548-549 (1993).
5. GÜNTHERT, U., HOFMAN, W., RUDY, S., REBER, S., ZÖLLER, M., MATZKU, S., WENZEL, A., PONTA, H. and HERRLICH, P., A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65, 13-24 (1991).
6. HEIDER, K.H., HOFMAN, M., HORS, E., VAN DEN BERG, F., PONTA, H., HERRLICH, P. and PALS, S.T., A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J. Cell BioL., 120, 227-233 (1993).
7. HOFMANN, M., RUDY, W., ZÖLLER, M., TOLG, C., PONTA, H., HERRLICH, P. and GÜNTHERT, U., CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res., 51, 5292-5297 (1991).
8. IDE, H., NAKAMURA, T., HAYASHI, K., ENDO, T., KOBAYASHI, A., EGUCHI, R. and HANYO, F., Esophageal squamous cell carcinoma: pathology and prognosis. World J. Surg., 18, 321-330 (1994).
9. IIZUKA, T., ISONO, K., KAEGAWA, T. and WATANABE, H., Parameters linked to 10 year survival in Japan of resected esophageal cancer. Chest, 96, 1005-1011 (1989).
10. ISHII, S., FORD, R. and THOMAS, P., CD44 participates in the adhesion of human colorectal carcinoma cells to laminin and type IV collagen. Surg. Oncol., 2, 255-264 (1993).
11. JALKANEN, S. and JALKANEN, M., Lymphocyte CD44 binds the COOH terminal heparin binding domain of fibronectin. J. Cell Biol., 105, 983-990 (1992).
12. JOENSUU, H., KLEMI, P.J., TOIKKANEN, S. and JALKANEN, S., Glycoprotein CD44 expression and its association with survival in breast cancer. Amer. J. Pathol., 143, 867-874 (1993).
13. KAPLAN, E.L. and MEIER, P., Nonparametric estimation from incomplete data. J. Amer. Statist. Assoc., 54, 457-481 (1958).
14. MACKAY, C.R., TERPE, H.J., STAUDER, R., MARSTON, W.L., STARK, H. and GUNTHERT, U., Expression and modulation of CD44 variant isoforms in humans. J. Cell Biol., 124, 71-82 (1994).
15. MANTEL, N., Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50, 163-170 (1992).
16. erb-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. J. nat. Cancer Inst., 86, 1140-1145 (1994).
17. PENNO, M.B., AUGUST, J.T., BAYLIN, S.B., MABRY, M., LINNOILA, R.I., LEE, V.S., CROTEAU, D., YANG, X.L. and ROSADA, C., Expression of CD44 in human lung tumors. Cancer Res., 54, 1381-1387 (1994).
18. ROBEY-CAFPERTY, S.S., EL-NAGgAR, A.K., SAHIN, A.A., BRUNER, J., RO, J.Y. and CLEARLY, K.R., Prognostic factors in esophageal squamous carcinoma: a study of histologic features, blood group expression and DNA ploidy. Amer. J. clin. Pathol., 95, 844-849 (1991).
19. SALLES, G., ZAIN, M., JIANG, W., BOUSSIOTIS, V.A. and SHIPP, M.A., Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies. Blood, 82, 3539-3547 (1993).
20. SAS INSTITUTE INC., SAS/STAT user's guide. Version 6, (4th ed.), vol. 2, Gary, NC: SAS Institute Inc., pp. 846 (1989).
21. SCREATON, G.R., BELL, D.G., JACKSON, F.B., GERTH, U. and BELL, J.I., Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. nat. Acad. Sci. (Wash.), 89, 12160-12164 (1992).
22. SHI, S.R., KEY, M.E. and KALRA, K.L., Antigen retrieval in formalinfixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem., 39, 741-748 (1991).
23. SY, M.S.,GUO, Y.J. and STAMENKOVIC, I., Distinct effects of two CD44 isoforms on tumor growth in vivo. J. exp. Med., 174, 859-866 (1991).
24. SY, M.S., Guo, Y.J. and STAMENKOVIC, I., Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J. exp. Med., 176, 623-627 (1992).
25. TANABE, K.K., ELLIS, L.M. and SAYA, H., Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet, 34, 725-726 (1993).
26. UNDERHILL, C., CD44: the hyaluronan receptor. J. Cell Sci., 103, 293-298 (1992).
27. WIELENGA, V.J., HEIDER, K.H., OFFERHAUS, G.J., ADOLF, G.R., VAN DL;N BERG, P.M., PONTA, H., HERRLICH, P. and PALS, S.T., Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res., 53, 4754-4756 (1993).